Ideal Group of Companies Inc. (IDGR)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ideal Group of Companies Inc. (IDGR) trades at $0.00. Ideal Group of Companies Inc. operates in the digital media and biotechnology sectors, targeting the 55+ active adult demographic with online content and exploring life extension technologies. Market cap: $433,263, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for IDGR: IDGR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IDGR against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IDGR: 1/1 perspectives are bearish.
How is this calculated? →Ideal Group of Companies Inc. (IDGR) Financial Services Profile
Ideal Group of Companies Inc. focuses on digital media for the 55+ demographic and strategic biotechnology acquisitions. Operating with a high gross margin of 100.0% and a beta of 0.21, the company navigates the financial services sector while exploring opportunities in human longevity, headquartered in Anderson, South Carolina.
What Is the Investment Thesis for IDGR?
Ideal Group of Companies Inc. presents a unique investment profile due to its dual focus on digital media and biotechnology. The company's digital media strategy, targeting the 55+ demographic, could drive revenue growth through increased content consumption and advertising opportunities. The strategic acquisitions in biotechnology and bioscience may provide long-term growth potential, although these ventures are inherently riskier and may require significant capital investment. With a profit margin of 0.8% and a gross margin of 100.0%, the company's financial performance needs to be closely monitored to ensure sustainable growth. Key catalysts include successful integration of acquired biotechnology assets and expansion of its digital media reach. Investors should carefully assess the risks associated with the company's OTC listing and the speculative nature of its biotechnology investments.
Based on FMP financials and quantitative analysis
IDGR Key Highlights
- Market capitalization of 433K indicates a micro-cap company with high growth potential but also higher risk.
- Gross margin of 100.0% suggests efficient content delivery or a business model with minimal direct costs, but needs further investigation to confirm sustainability.
- Profit margin of 0.8% indicates a need to improve operational efficiency and profitability despite high gross margins.
- Beta of 0.21 suggests the stock is significantly less volatile than the overall market, which may appeal to risk-averse investors.
- The company's strategic shift towards biotechnology and bioscience acquisitions could provide long-term growth opportunities but also introduces significant execution risk.
Who Are IDGR's Competitors?
IDGR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| SNFCA Security National Financial Corporation | $9.86 | +1.39% | $221.25M | 73 |
| BETRW Better Home & Finance Holding Company | $0.20 | -1.46% | $441.57M | 69 |
| ECPG Encore Capital Group, Inc. | $89.85 | -0.84% | $1.93B | 66 |
| VRTB Vestin Realty Mortgage II, Inc. | $3105.00 | +19.42% | $7.26M | 66 |
| IOR Income Opportunity Realty Investors, Inc. | $18.44 | +2.49% | $74.98M | 44 |
| IMH Impac Mortgage Holdings, Inc. | $0.22 | +0.00% | $8.22M | 45 |
| MMAC MMA Capital Holdings, Inc. | $27.77 | +0.00% | $11.26B | 45 |
| FNLIF First National Financial Corporation | $34.22 | +0.00% | $2.05B | 45 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IDGR's Key Strengths?
- Targeted content for the 55+ demographic.
- Strategic focus on biotechnology and bioscience.
- High gross margin (100.0%).
What Are IDGR's Weaknesses?
- Low profit margin (0.8%).
- OTC listing indicates higher risk.
- Limited financial information available.
What Could Drive IDGR Stock Higher?
- Expansion of digital media content offerings to attract a larger audience within the 55+ demographic.
- Strategic biotechnology acquisitions related to human life extension and human longevity.
- Development of targeted advertising solutions for businesses seeking to reach the 55+ demographic.
- Partnerships with healthcare providers to offer digital health and wellness programs.
- Expansion into international markets to tap into new growth opportunities.
What Are the Key Risks for IDGR?
- Insider selling — insiders were net sellers of roughly $17.7M recently.
- Competition from established digital media companies with greater resources and brand recognition.
- Regulatory hurdles and lengthy approval processes in the biotechnology industry.
- Economic downturn affecting advertising revenue and consumer spending.
- Limited financial disclosure and transparency due to OTC listing.
- Low liquidity and high bid-ask spreads making it difficult to trade shares.
What Are the Growth Opportunities for IDGR?
- Expansion of Digital Media Content: Ideal Group of Companies Inc. can expand its digital media content offerings to attract a larger audience within the 55+ demographic. This includes creating more diverse and engaging content, such as interactive programs, educational resources, and lifestyle-focused series. The market for senior-focused content is growing, with an estimated market size of $22 billion by 2027. Successful execution would involve strategic partnerships with content creators and effective marketing campaigns to reach the target audience. Timeline: Ongoing.
- Strategic Biotechnology Acquisitions: The company's focus on strategic biotechnology and bioscience acquisitions related to human life extension and human longevity presents a significant growth opportunity. The global market for longevity and anti-aging therapies is projected to reach $44.2 billion by 2030. Identifying and acquiring promising biotechnology companies with innovative technologies could drive long-term value creation. This requires careful due diligence and effective integration of acquired assets. Timeline: Ongoing.
- Development of Targeted Advertising Solutions: Ideal Group of Companies Inc. can leverage its understanding of the 55+ demographic to develop targeted advertising solutions for businesses seeking to reach this audience. This includes creating customized advertising campaigns, offering data-driven insights, and providing measurable results. The market for targeted advertising is growing rapidly, with an estimated market size of $100 billion by 2028. Successful execution would involve building strong relationships with advertisers and demonstrating the effectiveness of its advertising solutions. Timeline: Ongoing.
- Partnerships with Healthcare Providers: Collaborating with healthcare providers to offer digital health and wellness programs to the 55+ demographic can drive growth and enhance the company's market position. This includes developing online health education resources, offering virtual consultations, and providing remote monitoring services. The market for digital health solutions is expanding, with an estimated market size of $379 billion by 2024. Strategic partnerships with healthcare providers would enable the company to reach a wider audience and offer valuable services. Timeline: Ongoing.
- Expansion into International Markets: Ideal Group of Companies Inc. can expand its digital media and biotechnology offerings into international markets to tap into new growth opportunities. This includes adapting its content and services to meet the needs of diverse audiences and navigating regulatory requirements in different countries. The global market for digital media and biotechnology is vast, with significant growth potential in emerging markets. Successful execution would involve careful market research and strategic partnerships with local players. Timeline: Ongoing.
What Opportunities Does IDGR Have?
- Expansion of digital media content offerings.
- Successful development of biotechnology assets.
- Partnerships with healthcare providers.
What Threats Does IDGR Face?
- Competition from established digital media companies.
- Regulatory hurdles in the biotechnology industry.
- Economic downturn affecting advertising revenue.
What Are IDGR's Competitive Advantages?
- Targeted content for the 55+ demographic creates a niche market.
- Strategic biotechnology acquisitions provide potential for long-term growth.
- First-mover advantage in specific biotechnology niches.
- Brand recognition within the 55+ demographic.
What Does IDGR Do?
Ideal Group of Companies Inc., formerly known as JZZ Technologies, Inc., underwent a rebranding in January 2024 to reflect its evolving business strategy. Headquartered in Anderson, South Carolina, the company operates primarily in the digital media sector, creating and distributing content through online media, apps, and free over-the-air television. Their digital media efforts are specifically targeted at the 55+ active adult demographic, offering content creation, digital marketing, and streaming video services. Beyond digital media, Ideal Group of Companies Inc. is also pursuing strategic acquisitions in the biotechnology and bioscience fields, with a focus on human life extension and human longevity. This dual approach aims to capitalize on the growing demand for age-related content and advancements in biotechnological research. The company's business model encompasses both media technology and strategic investments in emerging health technologies. Ideal Group of Companies Inc. seeks to establish a foothold in both the digital content market and the rapidly evolving landscape of biotechnology.
What Products and Services Does IDGR Offer?
- Creates and distributes digital media content.
- Targets the 55+ active adult demographic.
- Offers online media and apps.
- Provides content creation services.
- Engages in digital marketing.
- Streams video content.
- Publishes content.
- Offers free over-the-air television.
How Does IDGR Make Money?
- Generates revenue through digital media advertising.
- Acquires and develops biotechnology assets.
- Potentially generates revenue from biotechnology products and services.
- Content subscriptions and licensing.
What Industry Does IDGR Operate In?
Ideal Group of Companies Inc. operates within the financial services sector, specifically focusing on mortgage-related activities while also venturing into the digital media and biotechnology industries. The digital media landscape is highly competitive, with established players like Netflix and YouTube dominating the market. The biotechnology industry is characterized by high research and development costs, regulatory hurdles, and long lead times for product development. Ideal Group of Companies Inc.'s success will depend on its ability to differentiate itself in both the digital media and biotechnology markets, while navigating the complexities of the financial services sector.
Who Are IDGR's Key Customers?
- Active adults aged 55 and over.
- Advertisers seeking to reach the 55+ demographic.
- Potential consumers of biotechnology products and services.
Company Profile
Ideal Group of Companies Inc. operates in the Financial - Mortgages industry within the Financial Services sector. It is headquartered in Anderson, US. The company is led by CEO Charles A. Cardona. IDGR has traded publicly since 2024.
Net sellingInsider Activity
The most recent 11 insider filings for Ideal Group of Companies Inc. break down as 9 sales and 2 purchases. On net that is roughly 1.5M shares disposed (about $17.7M), a signal worth weighing alongside the fundamentals.
IDGR Financials
Bull Case vs Bear Case
Bull Case
- Targeted content for the 55+ demographic.
- Strategic focus on biotechnology and bioscience.
- High gross margin (100.0%).
- Ongoing: Expansion of digital media content offerings to attract a larger audience within the 55+ demographic.
Bear Case
- Low profit margin (0.8%).
- OTC listing indicates higher risk.
- Limited financial information available.
- Potential: Competition from established digital media companies with greater resources and brand recognition.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
IDGR Latest News
No recent news available for IDGR.
IDGR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IDGR.
Price Targets
Wall Street price target analysis for IDGR.
IDGR MoonshotScore
What does this score mean?
The MoonshotScore rates IDGR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Charles A. Cardona
CEO
Information on Charles A. Cardona's background is limited. Further research is needed to determine his career history, education, and previous roles. A comprehensive understanding of his experience and expertise is crucial for assessing his leadership capabilities.
Track Record: Due to the limited information available, it is difficult to assess Charles A. Cardona's track record. Further research is needed to determine his key achievements, strategic decisions, and company milestones under his leadership.
IDGR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ideal Group of Companies Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and performance. Investing in OTC Other stocks involves a higher degree of risk compared to stocks listed on major exchanges like the NYSE or NASDAQ due to the lack of regulatory oversight and transparency.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low liquidity and high bid-ask spreads.
- Potential for price manipulation.
- Lack of regulatory oversight.
- Higher risk of fraud or mismanagement.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with the company's industry and operations.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company's history and operations.
- Presence of a functional website and contact information.
- Any news or press releases about the company.
- Verification of management team members.
- Independent audits of financial statements (if available).
IDGR Financial Services Stock FAQ
What does Ideal Group of Companies Inc. do?
Ideal Group of Companies Inc. operates as a media technology company focused on the digital media business, primarily targeting the 55+ active adult demographic. The company creates and distributes online content, apps, and streaming video, as well as offering digital marketing services. Additionally, Ideal Group of Companies Inc. is pursuing strategic acquisitions in the biotechnology and bioscience sectors, with a focus on human life extension and longevity. This dual approach aims to capitalize on the growing demand for age-related content and advancements in biotechnological research.
What do analysts say about IDGR stock?
As of 2026-03-17, there is no readily available analyst coverage or consensus on Ideal Group of Companies Inc. (IDGR) stock. This may be due to the company's small market capitalization and OTC listing, which often results in limited analyst attention. Investors should conduct their own thorough research and due diligence before making any investment decisions. Key valuation metrics and growth considerations should be carefully evaluated based on available financial information and industry trends.
What are the main risks for IDGR?
Ideal Group of Companies Inc. faces several risks, including competition from established digital media companies, regulatory hurdles in the biotechnology industry, and economic downturns affecting advertising revenue. The company's OTC listing also presents risks related to limited financial disclosure, low liquidity, and potential price volatility. Furthermore, the success of its biotechnology acquisitions depends on the successful development and commercialization of new technologies, which is inherently uncertain. Investors should carefully assess these risks before investing in IDGR.
What are the key factors to evaluate for IDGR?
Evaluate IDGR on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does IDGR data refresh on this page?
IDGR prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IDGR's recent stock price performance?
Ideal Group of Companies Inc. (IDGR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Targeted content for the 55+ demographic. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IDGR overvalued or undervalued right now?
Valuing Ideal Group of Companies Inc. (IDGR) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying IDGR?
Before investing in Ideal Group of Companies Inc. (IDGR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC listing indicates higher risk and limited regulatory oversight.
- AI analysis pending for IDGR.